0

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER از شرکت B BRAUN

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER از شرکت B BRAUN

New Drug Application (NDA): 065214

Company: B BRAUN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER CEFOXITIN SODIUM EQ 1GM BASE/VIAL INJECTABLE;INJECTION Prescription

AP

Yes Yes
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER CEFOXITIN SODIUM EQ 2GM BASE/VIAL INJECTABLE;INJECTION Prescription

AP

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/10/2006 ORIG-1 Approval

UNKNOWN

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
07/29/2019 SUPPL-16 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/065214s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/065214Orig1s016ltr.pdf

06/05/2013 SUPPL-13 Labeling-Package Insert

Label (PDF)

Letter (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065214s013lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/065214Orig1s013ltr.pdf

12/12/2012 SUPPL-12 Manufacturing (CMC)

Label is not available on this site.

02/22/2010 SUPPL-8 Labeling

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s008lbl.pdf

01/07/2008 SUPPL-5 Labeling

Label is not available on this site.

02/04/2010 SUPPL-2 Labeling

Label (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s002lbl.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
07/29/2019 SUPPL-16

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/065214s016lbl.pdf
06/05/2013 SUPPL-13

Labeling-Package Insert

Label (PDF)

Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/065214s013lbl.pdf
02/22/2010 SUPPL-8

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s008lbl.pdf
02/04/2010 SUPPL-2

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/065214s002lbl.pdf

CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER

INJECTABLE;INJECTION; EQ 1GM BASE/VIAL

TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CEFOXITIN CEFOXITIN SODIUM EQ 1GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065414 ACS DOBFAR
CEFOXITIN CEFOXITIN SODIUM EQ 1GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065238 HIKMA FARMACEUTICA
CEFOXITIN CEFOXITIN SODIUM EQ 1GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065051 WEST-WARD PHARMS INT
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER CEFOXITIN SODIUM EQ 1GM BASE/VIAL INJECTABLE;INJECTION Prescription Yes AP 065214 B BRAUN

INJECTABLE;INJECTION; EQ 2GM BASE/VIAL

TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CEFOXITIN CEFOXITIN SODIUM EQ 2GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065414 ACS DOBFAR
CEFOXITIN CEFOXITIN SODIUM EQ 2GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065238 HIKMA FARMACEUTICA
CEFOXITIN CEFOXITIN SODIUM EQ 2GM BASE/VIAL INJECTABLE;INJECTION Prescription No AP 065051 WEST-WARD PHARMS INT
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER CEFOXITIN SODIUM EQ 2GM BASE/VIAL INJECTABLE;INJECTION Prescription Yes AP 065214 B BRAUN
حتما بخوانید : ACYCLOVIR از شرکت KENTON

نظرات کاربران